BioSpace News Archive

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of people living with chronic skin conditions, will report financial results for the quarter ended September 30, 2019 and provide an operational update after market close on Tuesday, November 5, 2019.

Senseonics Holdings, Inc. announced that it plans to release its third quarter 2019 financial results after market close on Tuesday, November 12, 2019.

Sesen Bio, a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, reported modifications to its 2017 and 2018 common stock warrants, which enhance the Company’s capital raising optionality by allowing for future at-the-market programs.

IDEX Corporation announced its financial results for the three month period ended September 30, 2019.

Lantheus Holdings, Inc. announced Mary Anne Heino, President and Chief Executive Officer, will present at the Credit Suisse 28th Annual Healthcare Conference at 3:35 p.m. MT on Tuesday, November 12 at The Phoenician in Scottsdale, AZ.

Progyny, Inc. announced the closing of its initial public offering of 11,500,000 shares of its common stock, including the full exercise by the underwriters of their option to purchase 1,500,000 additional shares of common stock, at a price to the public of $13.00 per share.

Tech Start-up Commercializing Molecular Delivery Technology Discovered by a Nobel Laureate

Three new CVS Pharmacy stores to open in the Portland area by end of 2019, bringing a health-centric retail pharmacy experience to the market

New center of excellence aims to improve rates of cervical cancer screening, tobacco cessation

Cook Medical and Quanta System have entered into an agreement in which Cook will distribute in some territories a comprehensive offering of Quanta’s holmium and thulium laser systems, laser fibers and accessories.